Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

58132 Results Found

Public

AHA Comments on CMS’ Proposed Rule on Prior Authorization

AHA comments on CMS’ proposed rule on prior authorization.
Public

AHA Urges ONC to Further Delay Information Blocking Provisions

AHA urges the Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology to extend the deadline to comply with its final rule implementing information blocking provisions of the 21st Century Cures Act to 2022 or six months after the end of the COVID-19 public health emergency, whichever is later. The current deadline is April 5, 2021.
Public

Detailed Summary of Health Provisions in Consolidated Appropriations Act, 2021

The House and Senate last night approved the

Pfizer data indicates COVID-19 vaccine stability in non-ultra-cold temperatures

New data from Pfizer Inc. indicates that its COVID-19 vaccine is more stable than previously believed when stored -25°C to -15°C (-13°F to 5°F), temperatures more commonly found in pharmaceutical freezers and refrigerators.

AHA expresses support for legislation allowing providers to cross state lines to provide care during COVID-19 pandemic

The AHA today expressed support for the Temporary Reciprocity to Ensure Access to Treatment (TREAT) Act, which allows for the temporary reciprocity for treatment by medical professionals licensed in one state to patients in other states.

3M issues guidance on identifying counterfeit N95 respirators

3M recently released guidance to help customers identify fraudulent surgical respirators in response to growing reports of fraud related to three of its respirator models.

CMS extends guidance limiting hospital surveys

The Centers for Medicare & Medicaid Services extended until March 22 its guidance limiting the hospital survey process during the COVID-19 public health emergency.

CDC report: COVID-19 vaccine safety reporting for first 13.8M doses reassuring

Safety monitoring during the first month of the COVID-19 national vaccination program shows “reassuring safety profiles” for the Pfizer and Moderna COVID-19 vaccines, the Centers for Disease Control and Prevention reported.

Blog: Focus on health equity, information, and greater access to COVID-19 vaccines

Advancing health equity within communities of color disproportionately impacted by COVID-19 — and getting the facts straight about reasons for hesitancy over receiving vaccines — are priority issues for government policy influencers and health care organization leaders.